RESUMEN
Ultraviolet light exposure is the major risk factor for the development of squamous cell carcinoma in Caucasians. Mutations in the tumor suppressor gene p53 have been identified in both squamous cell carcinomas and basal cell carcinomas. The human homolog of the Drosophila patched gene, has been shown to be mutated in sporadic basal cell carcinomas; however, mutations in the patched gene have not been found in squamous cell carcinoma. In this study, we screened a total of 20 squamous cell carcinoma samples for mutations in the patched gene. Using polymerase chain reaction-single strand conformation polymorphism as an initial screening method, we identified one non-sense mutation, two mis-sense mutations and three silent mutations in five squamous cell carcinoma samples. In one squamous cell carcinoma sample, we identified a tandem GG-->AA transitional change at nucleotide 3152 in exon 18 of the patched gene that resulted in a premature stop codon at codon 1051. The three squamous cell carcinoma samples containing non-sense and mis-sense mutations were isolated from individuals with histories of multiple basal cell carcinoma. Sequence analysis of the p53 gene in these five squamous cell carcinoma samples identified one CC-->TT and three C-->T ultraviolet-specific nucleotide changes. Our study provides evidence that the patched gene is mutated in squamous cell carcinoma from individuals with a history of multiple basal cell carcinoma. The identification of ultraviolet-specific nucleotide changes in both tumor suppressor genes supports the notion that ultraviolet exposure plays an important part in the development of squamous cell carcinoma.
Asunto(s)
Carcinoma de Células Escamosas/genética , Proteínas de la Membrana/genética , Mutación , Neoplasias Cutáneas/genética , Anciano , Secuencia de Bases/genética , Codón/genética , Humanos , Masculino , Persona de Mediana Edad , Mutación/genética , Mutación Missense , Receptores Patched , Receptor Patched-1 , Reacción en Cadena de la Polimerasa , Polimorfismo Conformacional Retorcido-Simple , Receptores de Superficie CelularRESUMEN
UVB irradiation is known to produce DNA damage at mutation hotspots in the p53 tumor suppressor gene, leading to the development of skin cancers. Mutations in the PTCH tumor suppressor gene, which is known to be responsible for the development of nevoid basal cell carcinoma syndrome, have also been identified in sporadic basal cell carcinomas (BCCs). We describe the case of an 80-year-old welder in whom 3 novel p53 mutations, as well as UV-specific PTCH mutations, were detected in two BCC samples from sun-exposed skin. The simultaneous presence of UV-specific p53 and PTCH mutations in the same BCC sample has not previously been reported.
Asunto(s)
Carcinoma Basocelular/genética , Genes Supresores de Tumor/genética , Genes p53/genética , Proteínas de la Membrana/genética , Mutación , Neoplasias Inducidas por Radiación/genética , Neoplasias Cutáneas/genética , Luz Solar/efectos adversos , Anciano , Anciano de 80 o más Años , Eliminación de Gen , Genes Supresores de Tumor/efectos de la radiación , Genes p53/efectos de la radiación , Humanos , Pérdida de Heterocigocidad , Masculino , Proteínas de la Membrana/efectos de la radiación , Mutación Missense , Receptores Patched , Receptor Patched-1 , Mutación Puntual , Receptores de Superficie CelularRESUMEN
Basal cell carcinoma (BCC) is the most common skin cancer in the Western world. Ultraviolet (UV) exposure, race, age, gender, and decreased DNA repair capacity are known risk factors for the development of BCC. Of these, UVB irradiation from sunlight is the most significant risk factor. The incidence of sporadic BCC increases in individuals older than age 55, with the greatest incidence reported in individuals who are older than 70, and is rare in individuals who are younger than 30. In this study, we analyzed 24 BCC samples from individuals who had BCC diagnosed by the age of 30. Fifteen single-stranded conformation polymorphism variants in the PTCH gene were identified in 13 BCC samples. Sequence analysis of these single-stranded conformation polymorphism variants revealed 13 single nucleotide changes, one AT insertion, and one 15-bp deletion. Most of these nucleotide changes (nine of 15) were predicted to result in truncated PTCH proteins. Fifteen p53 mutations were also found in 11 of the 24 BCC samples. Thirty-three percent (five of 15) and 60% (nine of 15) of the nucleotide changes in the PTCH and p53 genes, respectively, were UV-specific C-->T and CC-->TT nucleotide changes. Our data demonstrate that the p53 and PTCH genes are both implicated in the development of early-onset BCC. The identification of UV-specific nucleotide changes in both tumor suppressor genes suggests that UV exposure is an important risk factor in early onset of BCC.
Asunto(s)
Carcinoma Basocelular/genética , Proteínas de la Membrana/genética , Proteína p53 Supresora de Tumor/genética , Adolescente , Adulto , Edad de Inicio , Sustitución de Aminoácidos , Secuencia de Bases , Carcinoma Basocelular/patología , ADN de Neoplasias/química , ADN de Neoplasias/genética , Femenino , Humanos , Masculino , Proteínas de la Membrana/fisiología , Mutación , Receptores Patched , Receptor Patched-1 , Mutación Puntual , Polimorfismo Conformacional Retorcido-Simple , Receptores de Superficie Celular , Análisis de Secuencia de ADN , Eliminación de Secuencia , Proteína p53 Supresora de Tumor/fisiologíaRESUMEN
Cowden syndrome (CS) is an autosomal dominant inherited disorder characterized by hamartomas in a variety of tissues including the skin, thyroid, breast, endometrium, and the brain. Individuals with CS are predisposed to development of malignancy in these organs, especially the breast and the thyroid. We describe 3 unrelated individuals with CS associated with germline PTEN mutations. While the frameshift (375insTTTA) and the missense (Gly69Arg) mutations reported herein are novel in CS, the nonsense (Arg130stop) mutation has been described in 2 families with CS and in a single family exhibiting both CS and Bannayan Zonana phenotype.
Asunto(s)
Mutación de Línea Germinal , Síndrome de Hamartoma Múltiple/genética , Monoéster Fosfórico Hidrolasas/genética , Proteínas Supresoras de Tumor , Adulto , Sustitución de Aminoácidos , ADN/genética , Elementos Transponibles de ADN , Femenino , Mutación del Sistema de Lectura/genética , Humanos , Masculino , Persona de Mediana Edad , Fosfohidrolasa PTENRESUMEN
Epidemiological studies have demonstrated that men with a family history of prostate cancer are at an increased risk for this disease. This important observation has led a number of research teams, including our own, to collect DNA samples and clinical data from prostate cancer families, with the goal of localizing and characterizing prostate cancer susceptibility genes. The candidate tumor suppressor gene PTEN (also called MMAC1) has recently been shown to be somatically altered in several common malignancies, including cancers of the brain, kidney, skin, thyroid, endometrium, breast, and prostate. Germ-line mutations in this gene, which maps to chromosome 10q23, have been associated with Cowden disease, an autosomal dominant cancer predisposition syndrome that is characterized by multiple hamartomas. Although prostate cancer is not typically associated with Cowden disease, previous studies of sporadic prostate cancers demonstrate loss of heterozygosity at 10q23 loci in approximately 25% of cases. We, therefore, hypothesized that germ-line mutations in the PTEN gene may predispose to prostate cancer in a subset of families, particularly those in which cancers of the breast, kidney, and/or thyroid also segregate. To test this hypothesis, DNA was isolated from whole blood of 11 prostate cancer patients from 10 unrelated families. Four of the 10 families met the previously established clinical criteria for hereditary prostate cancer. Eight of the II men had at least one second primary malignancy, including cases of neuroendocrine cancer, glioblastoma multiforme, melanoma, kidney, and thyroid cancer. Although we identified some common as well as some unique polymorphisms, no nonsense or missense mutations were identified in any of the 11 samples. To further examine the possibility that PTEN mutations contribute to prostate cancer predisposition, we also studied the probands from each of 10 families with early-onset and/or multiple individuals with prostate cancer. Sequence analysis of the PTEN gene in these 10 men also revealed no mutations or novel polymorphisms. We conclude that germ-line mutations in the PTEN are unlikely to contribute in a significant way to the inherited predisposition to prostate cancer.
Asunto(s)
Predisposición Genética a la Enfermedad , Mutación de Línea Germinal/genética , Monoéster Fosfórico Hidrolasas/genética , Neoplasias de la Próstata/genética , Proteínas Supresoras de Tumor , Adulto , Anciano , Pruebas Genéticas , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Primarias Secundarias/genética , Fosfohidrolasa PTEN , Reacción en Cadena de la Polimerasa , Polimorfismo Genético/genéticaRESUMEN
Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS) are two hamartoma syndromes with distinct phenotypic features. Although partial clinical overlap exists between CS and BZS, they are considered to be separate entities. PTEN has been identified as the susceptibility gene for both disorders, suggesting allelism. We have identified a germline mutation, R335X, in PTEN in a family consisting of two female members with the phenotypic findings of CS and two male members with the phenotypic findings of BZS. To our knowledge, this is the first report that shows the presence of separate subjects with CS and with BZS in a single family associated with a single germline PTEN mutation.
Asunto(s)
Anomalías Craneofaciales/patología , Mutación de Línea Germinal , Síndrome de Hamartoma Múltiple/patología , Monoéster Fosfórico Hidrolasas/genética , Proteínas Supresoras de Tumor , Adulto , Niño , Anomalías Craneofaciales/genética , Femenino , Síndrome de Hamartoma Múltiple/genética , Humanos , Masculino , Persona de Mediana Edad , Fosfohidrolasa PTEN , Linaje , Fenotipo , Análisis de Secuencia de ADN , SíndromeRESUMEN
Germline mutations in PTEN, a putative tumor suppressor gene, has been identified in 2 autosomal dominant inherited hamartoma syndromes, Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS). While both diseases exhibit distinct phenotypic features, there seems to be a partial clinical overlap between the 2 diseases. To date, 9 families with BZS have been screened for PTEN mutations, of which 5 were found to exhibit mutations in this gene. We report 5 novel germline mutations in the PTEN coding sequence from 5 unrelated families with the BZS phenotype. While all the mutations we identified are novel in BZS, 1003C-->T (nonsense mutation) and 209+5G-->A (putative splice site mutation) have been previously reported in unrelated families with CS and Lhermitte Duclos disease. Interestingly, 1 of the families has an individual with BZS and 1 with CS phenotype, associated with a single PTEN mutation, 885insA. These data support the notion that CS and BZS may be within the spectrum of the same primary disorder.
Asunto(s)
Mutación de Línea Germinal , Síndrome de Hamartoma Múltiple/genética , Monoéster Fosfórico Hidrolasas/genética , Mutación Puntual , Proteínas Supresoras de Tumor , Adulto , Sustitución de Aminoácidos , Secuencia de Bases , Niño , Preescolar , ADN/sangre , ADN/genética , Exones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fosfohidrolasa PTEN , Reacción en Cadena de la PolimerasaRESUMEN
Mutations in the PTEN/MMAC1 gene have been identified in several types of human cancers and cancer cell lines, including brain, endometrial, prostate, breast, thyroid, and melanoma. In this study, we screened a total of 96 hepatocellular carcinoma (HCC) samples from Taiwan, where HCC is the leading cancer in males and third leading cancer in females, for mutations in the PTEN/MMAC1 gene. Complete sequence analysis of these samples demonstrated a missense mutation in exon 5 (K144I) and exon 7 (V255A) from HCC samples B6-21 and B6-2, respectively. A putative splice site mutation was also detected in intron 3 from sample B6-2. Both B6-21 and B6-2 were previously shown to contain missense mutations in the coding sequences of the p53 gene. Functional studies with the two missense mutations demonstrated that while mutation V255A in exon 7 resulted in a loss of phosphatase activity, mutation K144I in exon 5 retained its phosphatase activity. Additionally, we identified a silent mutation (P96P) in exon 5 of the PTEN/MMAC1 gene from HCC sample B6-22. These data provide the first evidence that the PTEN/MMAC1 gene is mutated in a subset of HCC samples.
Asunto(s)
Carcinoma Hepatocelular/genética , Neoplasias Hepáticas/genética , Mutación , Monoéster Fosfórico Hidrolasas/genética , Proteínas Supresoras de Tumor , Secuencia de Bases , Carcinoma Hepatocelular/enzimología , Cartilla de ADN , Femenino , Genes Supresores de Tumor , Humanos , Neoplasias Hepáticas/enzimología , Masculino , Persona de Mediana Edad , Fosfohidrolasa PTEN , Monoéster Fosfórico Hidrolasas/metabolismoRESUMEN
Germline mutations in the PTEN gene have recently been identified in some individuals with Cowden disease (CD), Lhermitte-Duclos disease (LDD), and Bannayan-Zonana syndrome. We report on a patient with CD and LDD in whom a unique de novo germline missense mutation is present in the PTEN gene. Direct sequence analysis detected a transitional change (T-->C) at nucleotide 335, resulting in substitution of the amino acid proline for leucine. The mutation is in exon 5, which has been proposed as a "hot-spot" for germline mutations. Comparison of this patient's clinical course with the previously reported cases of CD and LDD shows more extensive and more severe clinical findings than reported previously. Findings in this patient contribute to the current understanding of germline PTEN mutations and clinical outcome.
Asunto(s)
Neoplasias Cerebelosas/genética , Ganglioneuroma/genética , Síndrome de Hamartoma Múltiple/genética , Monoéster Fosfórico Hidrolasas/genética , Proteínas Supresoras de Tumor , Adulto , Femenino , Mutación de Línea Germinal , Humanos , Mutación Missense , Fosfohidrolasa PTEN , Mutación Puntual , Enfermedades de la Piel/genética , SíndromeRESUMEN
Cowden's Syndrome (CS), or multiple hamartoma syndrome, is an autosomal dominant disorder characterized by mucocutaneous lesions, multiple benign tumors of internal organs and an increased risk of breast cancer. Here, we describe and illustrate in detail the benign breast pathology of 59 breast cases from 19 women with CS. Fibrosis is a significant characteristic of the breasts of patients with CS. Fibroadenomas appear to hyalinize at an early age and are frequently complex. The specimens demonstrate a spectrum of dense hyalinization of both the lobule and the stroma, and hyaline nodules appear to be the most characteristic lesion. This hyalinization process shares striking similarities with keloids, as well as the sclerotic nodules seen in the skin of CS individuals. Ductal carcinoma in CS was common, and it appeared to be associated with stromal hyalinization. Other frequently found benign features are adenosis and cysts. Of interest, the features of the benign breast disease in CS show certain similarities with senescent lobules, fibrous mastopathy of diabetes mellitus, and mammary hamartomas. These observations provide a framework for pathologists to identify this underrecognized syndrome.
Asunto(s)
Mama/patología , Síndrome de Hamartoma Múltiple/patología , Piel/patología , Adulto , Anciano , Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/patología , Femenino , Fibroadenoma/patología , Humanos , Persona de Mediana EdadRESUMEN
In previous studies, we have shown that the expression of retinoic acid receptor beta2 (RARbeta2) is altered in certain breast cancer cell lines. To investigate the mechanism responsible for this change, we studied in detail the RARbeta2 promoter in cell lines which demonstrated altered expression and compared these results to cell lines in which RARbeta2 was expressed normally. Direct DNA sequencing failed to identify alterations in the sequences of the known response elements in the cell lines manifesting altered expression patterns. By contrast, electrophoretic mobility shift studies of the proteins binding to these response elements demonstrated striking differences in the cells in which expression was altered, when compared to patterns seen in normal cells. Moreover, transient transfection studies using constructs of the RARbeta2 promoter demonstrated an absence of transactivation in the lines in which the expression of this gene was altered. These data suggest that the mechanism responsible for loss of induction of RARbeta2 in breast tumor cells is, at least in part, transcriptional repression.
Asunto(s)
Neoplasias de la Mama/genética , Regiones Promotoras Genéticas , Receptores de Ácido Retinoico/genética , Activación Transcripcional , Neoplasias de la Mama/metabolismo , Electroforesis en Gel de Poliacrilamida , Femenino , Regulación de la Expresión Génica , Humanos , Análisis de Secuencia de ADN , Transfección , Células Tumorales CultivadasRESUMEN
Cowden's syndrome (CS) is an autosomal dominant disorder associated with an increased risk of developing benign and malignant tumors in a variety of tissues, including the skin, thyroid, breast and brain. Women with CS are felt to have an increased risk of developing breast cancer, and virtually all women with CS develop bilateral fibrocystic disease of the breast. Recently, a series of germline mutations have been identified from CS families in a gene known as PTEN/MMAC1/TEP1. In this study, we used heteroduplex analysis and direct sequencing analysis and identified three novel germline mutations in the PTEN/MMAC1/TEP1 coding sequence from unrelated individuals with CS. We report a de novo transition (T-->C) at nucleotide 335 in exon 5. This missense mutation resulted in a leucine to proline (CTA to CCA) change at codon 112. We also describe a novel splice site mutation (801+2T-->G) in intron 7 that caused exon skipping in PTEN/MMAC1/TEP1 mRNA. The third mutation we report is a missense mutation, consisting of a transition (T-->C) at nucleotide 202 in exon 3, resulting in a tyrosine to histidine (TAC to CAC) change at codon 68. Finally, we also detected a rare polymorphism in exon 7 of the PTEN/MMAC1/TEP1 coding sequence. These data confirm the observation that mutations of the PTEN/MMAC1/TEP1 coding sequence are responsible for at least some cases of CS, and further define the spectrum of mutations in this autosomal dominant disorder.
Asunto(s)
Genes Supresores de Tumor , Mutación de Línea Germinal/genética , Síndrome de Hamartoma Múltiple/genética , Monoéster Fosfórico Hidrolasas , Proteínas Tirosina Fosfatasas/genética , Proteínas Supresoras de Tumor , Adulto , Anciano , Femenino , Humanos , Fosfohidrolasa PTEN , LinajeRESUMEN
There are several forms of hereditary human hair loss, known collectively as alopecias, the molecular bases of which are entirely unknown. A kindred with a rare, recessively inherited type of alopecia universalis was used to search for a locus by homozygosity mapping, and linkage was established in a 6-centimorgan interval on chromosome 8p12 (the logarithm of the odds favoring linkage score was 6.19). The human homolog of a murine gene, hairless, was localized in this interval by radiation hybrid mapping, and a missense mutation was found in affected individuals. Human hairless encodes a putative single zinc finger transcription factor protein with restricted expression in the brain and skin.
Asunto(s)
Alopecia/genética , Proteínas/genética , Dedos de Zinc , Secuencia de Aminoácidos , Animales , Encéfalo/metabolismo , Mapeo Cromosómico , Cromosomas Humanos Par 8 , Proteínas de Unión al ADN/genética , Femenino , Factores de Transcripción Forkhead , Expresión Génica , Genes Recesivos , Homocigoto , Humanos , Masculino , Ratones , Ratones Pelados/genética , Repeticiones de Microsatélite , Datos de Secuencia Molecular , Mutación , Linaje , Proteínas/química , Ratas , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Piel/metabolismo , Factores de Transcripción/genéticaRESUMEN
BACKGROUND: Some basal cell carcinomas (BCCs) contain genetic mutations, suggesting that the lesion is composed of a monoclonal population of cells. Clonality, a distinguishing feature of neoplasia, can be inferred by referencing clonal markers such as the pattern of X chromosome inactivation. The X-linked human androgen receptor gene (HUMARA; GenBank) contains a polymorphic DNA marker that reliably illustrates the pattern of X chromosome inactivation in a tissue. OBJECTIVE: Our purpose was to determine the clonality of sporadic BCCs by examining patterns of X chromosome inactivation. METHODS: The patterns of X chromosome inactivation in paired samples of normal skin and sporadic BCCs from 24 women were compared by means of the HUMARA gene assay. RESULTS: All samples from normal skin displayed random X chromosome inactivation, consistent with lyonization. In 15 of 25 tumor samples (60%), nonrandom X chromosome inactivation was detected, consistent with monoclonality. CONCLUSION: At least some sporadic BCCs are composed of a monoclonal population of cells, strengthening the contention that a collection of mutations confers a growth advantage to this epithelial lesion.
Asunto(s)
Carcinoma Basocelular/genética , Regulación Neoplásica de la Expresión Génica/genética , Neoplasias Cutáneas/genética , Cromosoma X/genética , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/genética , Carcinoma Basocelular/patología , Linaje de la Célula/genética , Células Clonales/patología , ADN de Neoplasias/genética , Células Epiteliales/patología , Femenino , Humanos , Persona de Mediana Edad , Mutación/genética , Polimorfismo Genético/genética , Receptores Androgénicos/genética , Reproducibilidad de los Resultados , Piel/citología , Piel/patología , Neoplasias Cutáneas/patologíaRESUMEN
Cowden's syndrome (CS), or multiple hamartoma syndrome, is an autosomal dominant disorder associated with benign skin tumors and an increased risk of breast cancer. In an effort to understand the basic mechanisms regulating the development of breast cancer in this patient population, as well as to define diagnostic aspects of the disorder, we describe for the first time the clinical and pathological spectrum of breast disease in CS. We obtained the clinical histories and examined the histopathology of 59 cases from 19 women with CS sent to us from a variety of institutions. The 19 women showed a spectrum of benign histopathological findings, including ductal hyperplasia, intraductal papillomatosis, adenosis, lobular atrophy, fibroadenomas, and fibrocystic change. Seventeen (89%) showed features suggestive of a breast hamartoma. Fourteen women (74%) showed malignant disease, most of which was ductal carcinoma. Twelve patients (86%) showed ductal carcinoma in situ (DCIS), and 12 (86%) showed infiltrating ductal carcinoma. One patient had only DCIS and another patient showed both infiltrating tubular carcinoma and lobular carcinoma in situ. Ten patients (71%) actually showed foci of tumor involving densely fibrotic, hamartomatous areas. In summary, we show that women with CS have a spectrum of exuberant benign and malignant breast pathology. A common benign breast lesion in CS is a densely fibrotic hyalinized nodule, whereas the most frequent breast malignancy is ductal carcinoma.
Asunto(s)
Enfermedades de la Mama/patología , Neoplasias de la Mama/patología , Síndrome de Hamartoma Múltiple/patología , Adulto , Anciano , Carcinoma in Situ/patología , Carcinoma Ductal de Mama/patología , Femenino , Enfermedad Fibroquística de la Mama/patología , Humanos , Hiperplasia/patología , Persona de Mediana Edad , Factores de RiesgoRESUMEN
Retinoic acid (RA) is known to exert profound effects on growth and differentiation in human dermal fibroblasts. In the observations presented here, we examined the regulation of expression of members of the RXR multigene family in human dermal fibroblasts. We showed that the messenger RNAs for both RXR alpha and RXR beta are expressed in human fibroblasts, but that the messenger RNA for RXR gamma is not detectable in these cells. Electrophoretic mobility shift studies of binding to the beta 2RARE in human dermal fibroblasts demonstrated that a single complex binds to beta 2RARE in the absence of RA. Stimulating cells with all-trans RA induced a second complex. An antibody to the RXR beta protein supershifted both complexes, while an antibody to the RXR alpha S/B protein had no effect on the binding. These data demonstrate that RXR beta plays an important role in retinoid-regulated signal transduction pathways in human dermal fibroblasts and the regulation of expression of the RXR gene family is different from that of the RAR gene family.
Asunto(s)
Fibroblastos/metabolismo , Receptores de Ácido Retinoico/metabolismo , Piel/metabolismo , Factores de Transcripción/metabolismo , Proteínas de Unión al ADN/metabolismo , Fibroblastos/citología , Expresión Génica , Humanos , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , Unión Proteica , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Mensajero/biosíntesis , Receptores X Retinoide , Piel/citologíaRESUMEN
Cowden syndrome (CS) is an autosomal dominant disorder associated with the development of hamartomas and benign tumors in a variety of tissues, including the skin, thyroid, breast, endometrium, and brain. It has been suggested that women with CS are at increased risk for breast cancer. A locus for CS was recently defined on chromosome 10 in 12 families, resulting in the identification of the CS critical interval, between the markers D10S215 and D10S541. More recently, affected individuals in four families with CS have been shown to have germ-line mutations in a gene known as "PTEN," or "MMAC1," which is located in the CS critical interval on chromosome 10. In this study, we report three novel MMAC1 mutations in CS and demonstrate that MMAC1 mutations are associated with CS and breast cancer. Furthermore, we also show that certain families and individuals with CS do not have mutations in the coding sequence of MMAC1. Finally, we did not detect MMAC1 mutations in a subpopulation of individuals with early-onset breast cancer, suggesting that germ-line mutations in this gene do not appear to be common in this group.
Asunto(s)
Neoplasias de la Mama/genética , Genes BRCA1 , Síndrome de Hamartoma Múltiple/genética , Monoéster Fosfórico Hidrolasas , Proteínas Tirosina Fosfatasas/genética , Proteínas Supresoras de Tumor , Cromosomas Humanos Par 10/genética , Femenino , Genes Dominantes , Marcadores Genéticos/genética , Haplotipos/genética , Humanos , Escala de Lod , Masculino , Mutación , Fosfohidrolasa PTEN , Linaje , Reacción en Cadena de la Polimerasa , Factores de Riesgo , Análisis de Secuencia de ADNRESUMEN
Cowden disease (CD) is an autosomal dominant cancer predisposition syndrome associated with an elevated risk for tumours of the breast, thyroid and skin. Lhermitte-Duclos disease (LDD) cosegregates with a subset of CD families and is associated with macrocephaly, ataxia and dysplastic cerebellar gangliocytomatosis. The common feature of these diseases is a predisposition to hamartomas, benign tumours containing differentiated but disorganized cells indigenous to the tissue of origin. Linkage analysis has determined that a single locus within chromosome 10q23 is likely to be responsible for both of these diseases. A candidate tumour suppressor gene (PTEN) within this region is mutated in sporadic brain, breast and prostate cancer. Another group has independently isolated the same gene, termed MMAC1, and also found somatic mutations throughout the gene in advanced sporadic cancers. Mutational analysis of PTEN in CD kindreds has identified germline mutations in four of five families. We found nonsense and missense mutations that are predicted to disrupt the protein tyrosine/dual-specificity phosphatase domain of this gene. Thus, PTEN appears to behave as a tumour suppressor gene in the germline. Our data also imply that PTEN may play a role in organizing the relationship of different cell types within an organ during development.
Asunto(s)
Genes Supresores de Tumor/genética , Mutación de Línea Germinal , Síndrome de Hamartoma Múltiple/genética , Monoéster Fosfórico Hidrolasas , Proteínas Tirosina Fosfatasas/genética , Proteínas Supresoras de Tumor , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/genética , Análisis Mutacional de ADN , Femenino , Humanos , Masculino , Fosfohidrolasa PTEN , Linaje , Polimorfismo GenéticoRESUMEN
The porphyrias are disorders that result from the inherited or acquired dysregulation of one of the eight enzymes in the heme biosynthetic pathway. Variegate porphyria (VP) is characterized by deficiencies in protoporphyrinogen oxidase (PPO) and has recently been genetically linked (Z = 6.62) to the PPO gene on chromosome 1q21. In this study, we have identified two sequence variants in the PPO gene in a family with VP. The first is a neutral polymorphism at the -47 position of intron 2; this polymorphism is present in the general population and is unlikely to underlie the VP phenotype. The second is a mutation in the PPO gene in a patient with VP; the mutation consists of an apparently de novo 2-bp insertion in exon 3 of PPO and results in a frameshift and downstream premature termination codon. These data establish that a frameshift mutation in PPO is the underlying mutation in this patient with VP and explain the sporadic occurrence of the phenotype in this family.
Asunto(s)
Cromosomas Humanos Par 1 , Elementos Transponibles de ADN , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH , Oxidorreductasas/genética , Porfiria Cutánea Tardía/genética , Porfirias Hepáticas/enzimología , Porfirias Hepáticas/genética , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Mapeo Cromosómico , Cartilla de ADN , Exones , Femenino , Flavoproteínas , Humanos , Masculino , Proteínas Mitocondriales , Datos de Secuencia Molecular , Núcleo Familiar , Linaje , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Porfobilinógeno/sangre , Porfiria Cutánea Tardía/enzimología , Porfirias Hepáticas/fisiopatología , Porfirinas/metabolismo , Protoporfirinógeno-OxidasaRESUMEN
Tumor cells represent a single clone of cells that have undergone a series of mutations in genomic DNA. This process, known as clonal evolution, is a distinguishing feature of cancer. The human androgen receptor gene (HUMARA; GenBank) contains a highly polymorphic cytosine-adenine-guanine trinucleotide repeat that can be used to determine clonality by depicting X chromosome inactivation patterns. Random X chromosome inactivation is consistent with polyclonality; nonrandom X chromosome inactivation indicates a clonal population of cells. Basal cell carcinoma (BCC) demonstrates an atypical growth pattern in that it grows slowly, rarely metastasizes, and is rarely lethal. Whether this tumor results from the accumulation of mutations in a single cell with subsequent clonal expansion or reflects a polyclonal response by a group of cells to a growth stimulus is unknown. To provide further insight into the molecular events characterizing BCCs, we determined the clonal origin of five modular BCCs from a female patient by analyzing X chromosome inactivation patterns at the HUMARA locus. All tumors demonstrated a nonrandom pattern of X chromosome inactivation, consistent with monoclonal proliferation. These findings provide strong genetic evidence that sporadic BCCs develop by clonal evolution and support the contention that a series of mutations in a single cell is responsible for the altered growth state seen in these transformed epithelial cells.